Ashley Kowalewski
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Lung Cancer Research Studies
- Cancer Cells and Metastasis
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 3
- Cancer Immunotherapy and Biomarkers 3
- Lung Cancer Research Studies 1
-
- Lung Cancer Treatments and Mutations 2
- Lung Cancer Diagnosis and Treatment 1
- Co-authors
- Hui Yu (4 shared papers)Christopher J. Rivard (3 shared papers)Fred R. Hirsch (3 shared papers)Ignacio I. Wistuba (2 shared papers)Jamaal Rehman (2 shared papers)Julia A. Bridge (2 shared papers)Cory Batenchuk (1 shared paper)Robert Homer (2 shared papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Ashley Kowalewski
5 papers receiving 763 citations
Ashley Kowalewski's Hit Papers
Peers
Comparison fields: 5 of 54
- Oncology 583
- Immunology 179
- Pulmonary and Respiratory Medicine 209
- Cancer Research 87
- Pathology and Forensic Medicine 36
Countries citing papers authored by Ashley Kowalewski
This map shows the geographic impact of Ashley Kowalewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Kowalewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Kowalewski more than expected).
Fields of papers citing papers by Ashley Kowalewski
This network shows the impact of papers produced by Ashley Kowalewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Kowalewski. The network helps show where Ashley Kowalewski may publish in the future.
Co-authors
The 25 scholars most cited alongside Ashley Kowalewski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non–Small Cell Lung Cancer Hit paper breakdown → | 2017 | 579 |
| 2 | 2016 | 151 | |
| 3 | 2015 | 29 | |
| 4 | 2016 | 8 | |
| 5 | EGFR IHC and FISH Correlative Analyses (SQUIRE Trial): necitumumab plus gemcitabine-cisplatin vs gemcitabine-cisplatin in 1st-line squamous NSCLC | 2015 | 4 |
About Ashley Kowalewski
Ashley Kowalewski is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, having authored 5 papers that have together received 771 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Treatments and Mutations (2 papers), Lung Cancer Research Studies (1 paper), Cancer Genomics and Diagnostics (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Medical Imaging Techniques and Applications (1 paper), Fibroblast Growth Factor Research (1 paper) and Lung Cancer Diagnosis and Treatment (1 paper). The work is most often cited by research in Oncology (583 citations), Immunology (179 citations), Pulmonary and Respiratory Medicine (209 citations), Cancer Research (87 citations) and Pathology and Forensic Medicine (36 citations). Ashley Kowalewski has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Hui Yu, Christopher J. Rivard, Fred R. Hirsch, Ignacio I. Wistuba, Jamaal Rehman, Julia A. Bridge, Cory Batenchuk, Robert Homer, Robert A. Anders and Gang Han. Their work appears in journals such as Journal of Thoracic Oncology, JAMA Oncology and Cancer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.